Cyclophilins in Atherosclerosis: A New Therapeutic Target?

E-ISSN： 1873-4286|19|33|5904-5908

ISSN： 1381-6128

Source： Current Pharmaceutical Design, Vol.19, Iss.33, 2013-10, pp. : 5904-5908

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Inflammation in Atherosclerosis: A New Therapeutic Target

Current Medicinal Chemistry - Anti-Inflammatory & Anti-Allergy Agents, Vol. 4, Iss. 3, 2005-06 ,pp. : 283-295

Bentham Science Publishers

Access to resources Recommend Favorite

A new therapeutic target for atherosclerosis treatment: interview with Uday Saxena

Expert Opinion on Therapeutic Targets, Vol. 10, Iss. 1, 2006-02 ,pp. : 1-3

Informa Healthcare

Access to resources Recommend Favorite

Cellular Repressor of E1A-stimulated Genes, A New Potential Therapeutic Target for Atherosclerosis

Current Drug Targets, Vol. 18, Iss. 15, 2017-10 ,pp. : 1800-1804

Bentham Science Publishers

Access to resources Recommend Favorite

Cholesterol ester transfer protein: a therapeutic target in atherosclerosis?

By Vourvouhaki Ekaterini Dedoussis George V

Expert Opinion on Therapeutic Targets, Vol. 12, Iss. 8, 2008-08 ,pp. : 937-948

Informa Healthcare

Access to resources Recommend Favorite

Inflammation: A Novel Therapeutic Target/Direction in Atherosclerosis

Current Pharmaceutical Design, Vol. 23, Iss. 8, 2017-04 ,pp. : 1216-1227

Bentham Science Publishers

Access to resources Recommend Favorite